世界の免疫化学分析装置開発動向:医療機器パイプライン分析2015

◆英語タイトル:Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2015
◆商品コード:GDME0147EPD
◆発行会社(調査会社):GlobalData
◆発行日:2016年1月5日
◆ページ数:265
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD8,000 ⇒換算¥880,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD12,000 ⇒換算¥1,320,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。



当調査レポートでは、免疫化学分析装置のグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。

・免疫化学分析装置の概要
・免疫化学分析装置の開発動向:開発段階別分析
・免疫化学分析装置の開発動向:セグメント別分析
・免疫化学分析装置の開発動向:領域別分析
・免疫化学分析装置の開発動向:規制Path別分析
・免疫化学分析装置の開発動向:承認日(推定)別分析
・企業別免疫化学分析装置の開発動向(パイプライン製品、進行中の治験)
・免疫化学分析装置の最近動向
【レポートの概要】

Immunochemistry Analyzers – Medical Devices Pipeline Assessment, 2015

Summary

GlobalData’s Medical Devices sector report, “Immunochemistry Analyzers – Medical Devices Pipeline Assessment, 2015″ provides an overview of Immunochemistry Analyzers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Immunochemistry Analyzers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Immunochemistry Analyzers under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Immunochemistry Analyzers and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Immunochemistry Analyzers under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 15
2 Introduction 16
2.1 Immunochemistry Analyzers Overview 16
3 Products under Development 18
3.1 Immunochemistry Analyzers – Pipeline Products by Stage of Development 18
3.2 Immunochemistry Analyzers – Pipeline Products by Segment 19
3.3 Immunochemistry Analyzers – Pipeline Products by Territory 20
3.4 Immunochemistry Analyzers – Pipeline Products by Regulatory Path 22
3.5 Immunochemistry Analyzers – Pipeline Products by Estimated Approval Date 23
3.6 Immunochemistry Analyzers – Ongoing Clinical Trials 24
4 Immunochemistry Analyzers – Pipeline Products under Development by Companies 25
4.1 Immunochemistry Analyzers Companies – Pipeline Products by Stage of Development 25
4.2 Immunochemistry Analyzers – Pipeline Products by Stage of Development 29
5 Immunochemistry Analyzers Companies and Product Overview 33
5.1 Acreo Swedish ICT AB Company Overview 33
5.1.1 Acreo Swedish ICT AB Pipeline Products & Ongoing Clinical Trials Overview 33
5.2 AESKU.Diagnostics GmbH & Co. KG Company Overview 34
5.2.1 AESKU.Diagnostics GmbH & Co. KG Pipeline Products & Ongoing Clinical Trials Overview 34
5.3 Akonni Biosystems, Inc. Company Overview 36
5.3.1 Akonni Biosystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.4 Arcxis Biotechnologies Inc. Company Overview 38
5.4.1 Arcxis Biotechnologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 38
5.5 Assay Dynamics, LLC Company Overview 39
5.5.1 Assay Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview 39
5.6 Atonomics A/S Company Overview 40
5.6.1 Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview 40
5.7 Beckman Coulter, Inc. Company Overview 42
5.7.1 Beckman Coulter, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.8 BioMedomics, Inc Company Overview 44
5.8.1 BioMedomics, Inc Pipeline Products & Ongoing Clinical Trials Overview 44
5.9 BioNanovations Corporation Company Overview 47
5.9.1 BioNanovations Corporation Pipeline Products & Ongoing Clinical Trials Overview 47
5.10 BioSIMS Company Overview 48
5.10.1 BioSIMS Pipeline Products & Ongoing Clinical Trials Overview 48
5.11 Boston University Company Overview 49
5.11.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 49
5.12 Canon U.S.A., Inc. Company Overview 51
5.12.1 Canon U.S.A., Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
5.13 CardioGenics Inc. Company Overview 52
5.13.1 CardioGenics Inc. Pipeline Products & Ongoing Clinical Trials Overview 52
5.14 Celsee Diagnostics, Inc. Company Overview 54
5.14.1 Celsee Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
5.15 Cepheid Company Overview 55
5.15.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 55
5.16 China Medical Technologies, Inc. Company Overview 58
5.16.1 China Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 58
5.17 ChipCare Corp Company Overview 61
5.17.1 ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview 61
5.18 Clearbridge BioLoc Pte Ltd Company Overview 65
5.18.1 Clearbridge BioLoc Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 65
5.19 Corgenix Medical Corporation Company Overview 66
5.19.1 Corgenix Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 66
5.20 Courtagen Life Sciences, Inc. Company Overview 68
5.20.1 Courtagen Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 68
5.21 Curetis N.V. Company Overview 69
5.21.1 Curetis N.V. Pipeline Products & Ongoing Clinical Trials Overview 69
5.22 Denator AB Company Overview 78
5.22.1 Denator AB Pipeline Products & Ongoing Clinical Trials Overview 78
5.23 DiaSorin S.p.A Company Overview 79
5.23.1 DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview 79
5.24 Dyamed Biotech Pte Ltd Company Overview 81
5.24.1 Dyamed Biotech Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 81
5.25 Dynex Technologies Company Overview 82
5.25.1 Dynex Technologies Pipeline Products & Ongoing Clinical Trials Overview 82
5.26 EKF Diagnostics Holdings Plc Company Overview 83
5.26.1 EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 83
5.27 Enigma Diagnostics Limited Company Overview 85
5.27.1 Enigma Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview 85
5.28 F Cubed LLC Company Overview 86
5.28.1 F Cubed LLC Pipeline Products & Ongoing Clinical Trials Overview 86
5.29 Firalis SAS Company Overview 87
5.29.1 Firalis SAS Pipeline Products & Ongoing Clinical Trials Overview 87
5.30 First Light Biosciences, Inc. Company Overview 89
5.30.1 First Light Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 89
5.31 Florida State University Company Overview 90
5.31.1 Florida State University Pipeline Products & Ongoing Clinical Trials Overview 90
5.32 GenePOC Inc. Company Overview 91
5.32.1 GenePOC Inc. Pipeline Products & Ongoing Clinical Trials Overview 91
5.33 Genera Biosystems Limited Company Overview 93
5.33.1 Genera Biosystems Limited Pipeline Products & Ongoing Clinical Trials Overview 93
5.34 Genevo Biosystems Pte Ltd Company Overview 95
5.34.1 Genevo Biosystems Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 95
5.35 GenMark Diagnostics, Inc. Company Overview 96
5.35.1 GenMark Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 96
5.36 Global Solutions for Infectious Diseases Company Overview 98
5.36.1 Global Solutions for Infectious Diseases Pipeline Products & Ongoing Clinical Trials Overview 98
5.37 GNA Biosolutions GmbH Company Overview 100
5.37.1 GNA Biosolutions GmbH Pipeline Products & Ongoing Clinical Trials Overview 100
5.38 Harvard University Company Overview 102
5.38.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview 102
5.39 HeatFlow Technologies, Inc. Company Overview 103
5.39.1 HeatFlow Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 103
5.40 Hologic, Inc. Company Overview 104
5.40.1 Hologic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 104
5.41 HTG Molecular Diagnostics, Inc. Company Overview 106
5.41.1 HTG Molecular Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 106
5.42 Immunexpress Pty Ltd Company Overview 108
5.42.1 Immunexpress Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 108
5.43 Immunodiagnostic Systems Holdings plc Company Overview 109
5.43.1 Immunodiagnostic Systems Holdings plc Pipeline Products & Ongoing Clinical Trials Overview 109
5.44 Intelligent Fingerprinting Ltd Company Overview 110
5.44.1 Intelligent Fingerprinting Ltd Pipeline Products & Ongoing Clinical Trials Overview 110
5.45 Johnson & Johnson Company Overview 111
5.45.1 Johnson & Johnson Pipeline Products & Ongoing Clinical Trials Overview 111
5.46 LaserGen, Inc. Company Overview 114
5.46.1 LaserGen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 114
5.47 Lucerna, Inc. Company Overview 115
5.47.1 Lucerna, Inc. Pipeline Products & Ongoing Clinical Trials Overview 115
5.48 Magellan Diagnostics, Inc. Company Overview 116
5.48.1 Magellan Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 116
5.49 Magnisense SAS Company Overview 117
5.49.1 Magnisense SAS Pipeline Products & Ongoing Clinical Trials Overview 117
5.50 MAST GROUP Ltd. Company Overview 118
5.50.1 MAST GROUP Ltd. Pipeline Products & Ongoing Clinical Trials Overview 118
5.51 Maxygen-mobile DNA tests Company Overview 119
5.51.1 Maxygen-mobile DNA tests Pipeline Products & Ongoing Clinical Trials Overview 119
5.52 mBio Diagnostics, Inc. Company Overview 120
5.52.1 mBio Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 120
5.53 McKesson Corporation Company Overview 123
5.53.1 McKesson Corporation Pipeline Products & Ongoing Clinical Trials Overview 123
5.54 MedNostic Technologies, LLC Company Overview 125
5.54.1 MedNostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 125
5.55 Mindray Medical International Limited Company Overview 126
5.55.1 Mindray Medical International Limited Pipeline Products & Ongoing Clinical Trials Overview 126
5.56 Mobidiag Ltd. Company Overview 128
5.56.1 Mobidiag Ltd. Pipeline Products & Ongoing Clinical Trials Overview 128
5.57 NanoLab, Inc. Company Overview 130
5.57.1 NanoLab, Inc. Pipeline Products & Ongoing Clinical Trials Overview 130
5.58 Nanosphere, Inc. Company Overview 132
5.58.1 Nanosphere, Inc. Pipeline Products & Ongoing Clinical Trials Overview 132
5.59 Next Dimension Technologies, Inc. Company Overview 134
5.59.1 Next Dimension Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 134
5.60 NorthShore University Health System Company Overview 135
5.60.1 NorthShore University Health System Pipeline Products & Ongoing Clinical Trials Overview 135
5.61 OncoGenesis Company Overview 136
5.61.1 OncoGenesis Pipeline Products & Ongoing Clinical Trials Overview 136
5.62 Optidet Diagnostics Ltd Company Overview 137
5.62.1 Optidet Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 137
5.63 Optofluidics, Inc. Company Overview 138
5.63.1 Optofluidics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 138
5.64 Ostendum R&D BV Company Overview 139
5.64.1 Ostendum R&D BV Pipeline Products & Ongoing Clinical Trials Overview 139
5.65 Polymedco CDP, LLC Company Overview 140
5.65.1 Polymedco CDP, LLC Pipeline Products & Ongoing Clinical Trials Overview 140
5.66 Protomex Life Sciences Company Overview 141
5.66.1 Protomex Life Sciences Pipeline Products & Ongoing Clinical Trials Overview 141
5.67 Qiagen N.V. Company Overview 142
5.67.1 Qiagen N.V. Pipeline Products & Ongoing Clinical Trials Overview 142
5.68 Quanterix Corporation Company Overview 148
5.68.1 Quanterix Corporation Pipeline Products & Ongoing Clinical Trials Overview 148
5.69 QuantuMDx Group Limited Company Overview 149
5.69.1 QuantuMDx Group Limited Pipeline Products & Ongoing Clinical Trials Overview 149
5.70 Quidel Corporation Company Overview 150
5.70.1 Quidel Corporation Pipeline Products & Ongoing Clinical Trials Overview 150
5.71 Radisens Diagnostics Limited Company Overview 152
5.71.1 Radisens Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview 152
5.72 Raman Diagnostics Limited Company Overview 154
5.72.1 Raman Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview 154
5.73 Rapid Biosensor Systems Company Overview 155
5.73.1 Rapid Biosensor Systems Pipeline Products & Ongoing Clinical Trials Overview 155
5.74 Rapid Diagnostek, Inc. Company Overview 156
5.74.1 Rapid Diagnostek, Inc. Pipeline Products & Ongoing Clinical Trials Overview 156
5.75 Siemens Healthcare Diagnostics Inc. Company Overview 157
5.75.1 Siemens Healthcare Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 157
5.76 Siloam Biosciences, Inc. Company Overview 159
5.76.1 Siloam Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 159
5.77 Singulex, Inc. Company Overview 160
5.77.1 Singulex, Inc. Pipeline Products & Ongoing Clinical Trials Overview 160
5.78 Spire Corporation Company Overview 162
5.78.1 Spire Corporation Pipeline Products & Ongoing Clinical Trials Overview 162
5.79 Stat-Diagnostica & Innovation, S.L. Company Overview 164
5.79.1 Stat-Diagnostica & Innovation, S.L. Pipeline Products & Ongoing Clinical Trials Overview 164
5.80 STRATEC Molecular GmbH Company Overview 165
5.80.1 STRATEC Molecular GmbH Pipeline Products & Ongoing Clinical Trials Overview 165
5.81 Sysmex Corporation Company Overview 167
5.81.1 Sysmex Corporation Pipeline Products & Ongoing Clinical Trials Overview 167
5.82 Tecan Group Ltd Company Overview 169
5.82.1 Tecan Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 169
5.83 Techcomp (Holdings) Limited Company Overview 170
5.83.1 Techcomp (Holdings) Limited Pipeline Products & Ongoing Clinical Trials Overview 170
5.84 The Palo Alto Research Center Company Overview 172
5.84.1 The Palo Alto Research Center Pipeline Products & Ongoing Clinical Trials Overview 172
5.85 TrovaGene, Inc. Company Overview 173
5.85.1 TrovaGene, Inc. Pipeline Products & Ongoing Clinical Trials Overview 173
5.86 Tyncbest Biotechnology Company Overview 175
5.86.1 Tyncbest Biotechnology Pipeline Products & Ongoing Clinical Trials Overview 175
5.87 University of California, Davis Company Overview 177
5.87.1 University of California, Davis Pipeline Products & Ongoing Clinical Trials Overview 177
5.88 University of California, San Diego Company Overview 178
5.88.1 University of California, San Diego Pipeline Products & Ongoing Clinical Trials Overview 178
5.89 University of Michigan Company Overview 180
5.89.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 180
5.90 University of Michigan Pediatric Device Consortium Company Overview 181
5.90.1 University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 181
5.91 Wellstat Diagnostics, LLC Company Overview 182
5.91.1 Wellstat Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview 182
5.92 Xanthostat Diagnostics, Inc. Company Overview 184
5.92.1 Xanthostat Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 184
5.93 ZIN Technologies, Inc. Company Overview 185
5.93.1 ZIN Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 185
6 Immunochemistry Analyzers- Recent Developments 186
7 Appendix 262
7.1 Methodology 262
7.2 About GlobalData 264
7.3 Contact Us 265
7.4 Disclaimer 265

1.1 List of Tables
Table 1: Immunochemistry Analyzers - Pipeline Products by Stage of Development 18
Table 2: Immunochemistry Analyzers - Pipeline Products by Segment 19
Table 3: Immunochemistry Analyzers - Pipeline Products by Territory 21
Table 4: Immunochemistry Analyzers - Pipeline Products by Regulatory Path 22
Table 5: Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date 23
Table 6: Immunochemistry Analyzers - Ongoing Clinical Trials 24
Table 7: Immunochemistry Analyzers Companies - Pipeline Products by Stage of Development 25
Table 8: Immunochemistry Analyzers - Pipeline Products by Stage of Development 29
Table 9: Acreo Swedish ICT AB Pipeline Products & Ongoing Clinical Trials Overview 33
Table 10: Electronic Nanowire Bio - Sensor - Product Status 33
Table 11: Electronic Nanowire Bio - Sensor - Product Description 33
Table 12: AESKU.Diagnostics GmbH & Co. KG Pipeline Products & Ongoing Clinical Trials Overview 34
Table 13: HELIOS - Product Status 35
Table 14: HELIOS - Product Description 35
Table 15: Akonni Biosystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
Table 16: TruDiagnosis System - Product Status 37
Table 17: TruDiagnosis System - Product Description 37
Table 18: Arcxis Biotechnologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 38
Table 19: BioPhalanx Analyzer - Product Status 38
Table 20: BioPhalanx Analyzer - Product Description 38
Table 21: Assay Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview 39
Table 22: Automated Diagnostic Device - Product Status 39
Table 23: Automated Diagnostic Device - Product Description 39
Table 24: Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview 40
Table 25: Atolyzer Gene - Product Status 40
Table 26: Atolyzer Gene - Product Description 40
Table 27: Atolyzer PoC - Product Status 41
Table 28: Atolyzer PoC - Product Description 41
Table 29: Beckman Coulter, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
Table 30: UniCel DxN - Product Status 43
Table 31: UniCel DxN - Product Description 43
Table 32: BioMedomics, Inc Pipeline Products & Ongoing Clinical Trials Overview 44
Table 33: Next Generation Ultra-sensitive Nanotube Platform - Product Status 45
Table 34: Next Generation Ultra-sensitive Nanotube Platform - Product Description 45
Table 35: TR-LFIA Diagnostic Platform - Product Status 46
Table 36: TR-LFIA Diagnostic Platform - Product Description 46
Table 37: BioNanovations Corporation Pipeline Products & Ongoing Clinical Trials Overview 47
Table 38: TestQuick - Product Status 47
Table 39: TestQuick - Product Description 47
Table 40: BioSIMS Pipeline Products & Ongoing Clinical Trials Overview 48
Table 41: DigiPLEX Analyzer - Product Status 48
Table 42: DigiPLEX Analyzer - Product Description 48
Table 43: Boston University Pipeline Products & Ongoing Clinical Trials Overview 49
Table 44: Lab-On-A-Chip - Thyroid Cancer - Product Status 49
Table 45: Lab-On-A-Chip - Thyroid Cancer - Product Description 49
Table 46: Real-Time Multiplexed Diagnostic System - Hemorrhagic Fever - Product Status 50
Table 47: Real-Time Multiplexed Diagnostic System - Hemorrhagic Fever - Product Description 50
Table 48: Canon U.S.A., Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
Table 49: Automated Diagnostic System - Infectious Disease - Product Status 51
Table 50: Automated Diagnostic System - Infectious Disease - Product Description 51
Table 51: CardioGenics Inc. Pipeline Products & Ongoing Clinical Trials Overview 52
Table 52: QL Care Analyzer - Product Status 53
Table 53: QL Care Analyzer - Product Description 53
Table 54: Celsee Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
Table 55: Imaging-And-Microfluidics Chip - Product Status 54
Table 56: Imaging-And-Microfluidics Chip - Product Description 54
Table 57: Cepheid Pipeline Products & Ongoing Clinical Trials Overview 55
Table 58: GeneXpert Omni - Product Status 56
Table 59: GeneXpert Omni - Product Description 56
Table 60: GeneXpert Omni CLIA-Waived Point-of-Care System - Product Status 57
Table 61: GeneXpert Omni CLIA-Waived Point-of-Care System - Product Description 57
Table 62: China Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 58
Table 63: AUTOLIA-12/48 - Product Status 59
Table 64: AUTOLIA-12/48 - Product Description 59
Table 65: Second Generation SPR Analyzer - Product Status 60
Table 66: Second Generation SPR Analyzer - Product Description 60
Table 67: ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview 61
Table 68: Portable Cell Analyzer - Food Borne Diseases - Product Status 61
Table 69: Portable Cell Analyzer - Food Borne Diseases - Product Description 61
Table 70: Portable Cell Analyzer - HIV - Product Status 62
Table 71: Portable Cell Analyzer - HIV - Product Description 62
Table 72: Portable Cell Analyzer - Malaria - Product Status 63
Table 73: Portable Cell Analyzer - Malaria - Product Description 63
Table 74: Portable Cell Analyzer - Tuberculosis - Product Status 64
Table 75: Portable Cell Analyzer - Tuberculosis - Product Description 64
Table 76: Clearbridge BioLoc Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 65
Table 77: AssayQuest - Product Status 65
Table 78: AssayQuest - Product Description 65
Table 79: Corgenix Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 66
Table 80: ELISA Microplate Reader - Product Status 67
Table 81: ELISA Microplate Reader - Product Description 67
Table 82: Courtagen Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 68
Table 83: Avantra Q400 Biomarker Workstation - Product Status 68
Table 84: Avantra Q400 Biomarker Workstation - Product Description 68
Table 85: Curetis N.V. Pipeline Products & Ongoing Clinical Trials Overview 69
Table 86: Unyvero Blood Stream Infection Cartridge - Product Status 70
Table 87: Unyvero Blood Stream Infection Cartridge - Product Description 70
Table 88: Unyvero i60 Cartridge - Product Status 71
Table 89: Unyvero i60 Cartridge - Product Description 71
Table 90: Unyvero P50 LRT - Product Status 72
Table 91: Unyvero P50 LRT - Product Description 72
Table 92: Unyvero P55 LRT Pneumonia - Product Status 73
Table 93: Unyvero P55 LRT Pneumonia - Product Description 73
Table 94: Unyvero Tuberculosis Cartridge - Product Status 74
Table 95: Unyvero Tuberculosis Cartridge - Product Description 74
Table 96: Curetis N.V. - Ongoing Clinical Trials Overview 75
Table 97: Unyvero P50 LRT - Detection of Microorganisms and Antibiotic Resistance Genes in Lower Respiratory Tract (LRT) Samples Using the Curetis Unyvero LRT55 Application 76
Table 98: Unyvero P55 LRT Pneumonia - Clinical CE Performance Evaluation of Unyvero P55 Pneumonia Application 77
Table 99: Unyvero P55 LRT Pneumonia - Next Phase of Unyvero U.S. FDA Trial in Lower Respiratory Tract 77
Table 100: Denator AB Pipeline Products & Ongoing Clinical Trials Overview 78
Table 101: Biomarker Discovery Platform - Cancer - Product Status 78
Table 102: Biomarker Discovery Platform - Cancer - Product Description 78
Table 103: DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview 79
Table 104: LIAISON XS - Product Status 80
Table 105: LIAISON XS - Product Description 80
Table 106: Dyamed Biotech Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 81
Table 107: MicroKit AIO - Product Status 81
Table 108: MicroKit AIO - Product Description 81
Table 109: Dynex Technologies Pipeline Products & Ongoing Clinical Trials Overview 82
Table 110: Agility 12-Plate System - Product Status 82
Table 111: Agility 12-Plate System - Product Description 82
Table 112: EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 83
Table 113: BIOSEN HbA1c Instrument - Product Status 84
Table 114: BIOSEN HbA1c Instrument - Product Description 84
Table 115: Enigma Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview 85
Table 116: Enigma XL System - Product Status 85
Table 117: Enigma XL System - Product Description 85
Table 118: F Cubed LLC Pipeline Products & Ongoing Clinical Trials Overview 86
Table 119: Nesdep - Product Status 86
Table 120: Nesdep - Product Description 86
Table 121: Firalis SAS Pipeline Products & Ongoing Clinical Trials Overview 87
Table 122: Micro-ELISA System - Product Status 88
Table 123: Micro-ELISA System - Product Description 88
Table 124: First Light Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 89

1.2 List of Figures
Figure 1: Immunochemistry Analyzers - Pipeline Products by Stage of Development 18
Figure 2: Immunochemistry Analyzers - Pipeline Products by Segment 19
Figure 3: Immunochemistry Analyzers - Pipeline Products by Territory 20
Figure 4: Immunochemistry Analyzers - Pipeline Products by Regulatory Path 22
Figure 5: Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date 23
Figure 6: Immunochemistry Analyzers - Ongoing Clinical Trials 24

【掲載企業】

Acreo Swedish ICT AB
AESKU.Diagnostics GmbH & Co. KG
Akonni Biosystems, Inc.
Arcxis Biotechnologies Inc.
Assay Dynamics, LLC
Atonomics A/S
Beckman Coulter, Inc.
BioMedomics, Inc
BioNanovations Corporation
BioSIMS
Boston University
Canon U.S.A., Inc.
CardioGenics Inc.
Celsee Diagnostics, Inc.
Cepheid
China Medical Technologies, Inc.
ChipCare Corp
Clearbridge BioLoc Pte Ltd
Corgenix Medical Corporation
Courtagen Life Sciences, Inc.
Curetis N.V.
Denator AB
DiaSorin S.p.A
Dyamed Biotech Pte Ltd
Dynex Technologies
EKF Diagnostics Holdings Plc
Enigma Diagnostics Limited
F Cubed LLC
Firalis SAS
First Light Biosciences, Inc.
Florida State University
GenePOC Inc.
Genera Biosystems Limited
Genevo Biosystems Pte Ltd
GenMark Diagnostics, Inc.
Global Solutions for Infectious Diseases
GNA Biosolutions GmbH
Harvard University
HeatFlow Technologies, Inc.
Hologic, Inc.
HTG Molecular Diagnostics, Inc.
Immunexpress Pty Ltd
Immunodiagnostic Systems Holdings plc
Intelligent Fingerprinting Ltd
Johnson & Johnson
LaserGen, Inc.
Lucerna, Inc.
Magellan Diagnostics, Inc.
Magnisense SAS
MAST GROUP Ltd.
Maxygen-mobile DNA tests
mBio Diagnostics, Inc.
McKesson Corporation
MedNostic Technologies, LLC
Mindray Medical International Limited
Mobidiag Ltd.
NanoLab, Inc.
Nanosphere, Inc.
Next Dimension Technologies, Inc.
NorthShore University Health System
OncoGenesis
Optidet Diagnostics Ltd
Optofluidics, Inc.
Ostendum R&D BV
Polymedco CDP, LLC
Protomex Life Sciences
Qiagen N.V.
Quanterix Corporation
QuantuMDx Group Limited
Quidel Corporation
Radisens Diagnostics Limited
Raman Diagnostics Limited
Rapid Biosensor Systems
Rapid Diagnostek, Inc.
Siemens Healthcare Diagnostics Inc.
Siloam Biosciences, Inc.
Singulex, Inc.
Spire Corporation
Stat-Diagnostica & Innovation, S.L.
STRATEC Molecular GmbH
Sysmex Corporation
Tecan Group Ltd
Techcomp (Holdings) Limited
The Palo Alto Research Center
TrovaGene, Inc.
Tyncbest Biotechnology
University of California, Davis
University of California, San Diego
University of Michigan
University of Michigan Pediatric Device Consortium
Wellstat Diagnostics, LLC
Xanthostat Diagnostics, Inc.
ZIN Technologies, Inc.

【レポートのキーワード】

免疫化学分析装置

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[世界の免疫化学分析装置開発動向:医療機器パイプライン分析2015]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。H&I文字はH&Iグローバルリサーチ株式会社の商標(登録第5783645号)です。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。
※当サイトでは2016年05月24日現在 190,338 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆